Contineum Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Contineum Therapeutics Inc
CIK #0001855175
EDGAR Form CIK 2011 - 2026
10-K [0001855175]
10-Q [0001855175]
3 [0001855175]
4 [0001855175]
8-K [0001855175]
SC 13G [0001855175]
Form 13D/13G Filer Form 13D/13G Subject Filed
Balyasny Asset Management LP Contineum Therapeutics Inc [2026-05-15]
Millennium Management LLC Contineum Therapeutics Inc [2026-04-17]
Janus Henderson Group PLC Contineum Therapeutics Inc [2026-02-17]
Balyasny Asset Management LP Contineum Therapeutics Inc [2026-02-17]
RA Capital Management LP Contineum Therapeutics Inc [2025-07-25]
Sectoral Asset Management Inc Contineum Therapeutics Inc [2024-11-14]
Franklin Resources Inc Contineum Therapeutics Inc [2024-10-31]
Perceptive Advisors LLC Contineum Therapeutics Inc [2024-04-15]
Suvretta Capital Management LLC Contineum Therapeutics Inc [2024-04-15]
Johnson & Johnson Contineum Therapeutics Inc [2024-04-10]
Form 3/4/5 Subject 2011 - 2026
Stengone Carmine N
Contineum Therapeutics Inc
Lorrain Daniel S
Watkins Tim
Schimmelpennink Evert B
Ignelzi Troy A
Brady Todd R
Boyce Sarah
Miralles Gines Diego
Lyons-Williams Lori
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Contineum Therapeutics Inc CTNM
Class A Common Stock
2026-03-02 Sell 4,170 $15.01 62,592
Contineum Therapeutics Inc CTNM
Class A Common Stock
2026-03-02 Sell 3,611 $15.02 54,237
Contineum Therapeutics Inc CTNM
Class A Common Stock
2026-03-02 Option exercise 3,611 $4.50 16,250
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
2026-03-02 Option exercise 3,611 $0.00
Contineum Therapeutics Inc CTNM
Class A Common Stock
2026-02-25 Sell 3,824 $16.01 61,222
Contineum Therapeutics Inc CTNM
Class A Common Stock
2026-02-25 Option exercise 3,824 $1.01 3,862
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
2026-02-25 Option exercise 3,824 $0.00
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
2026-02-25 Option exercise 2,700 $0.00
Contineum Therapeutics Inc CTNM
Class A Common Stock
2026-02-25 Option exercise 2,700 $1.26 3,402
Contineum Therapeutics Inc CTNM
Class A Common Stock
2026-02-25 Sell 2,700 $16.02 43,254
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
2026-02-24 Option exercise 4,300 $0.00
Contineum Therapeutics Inc CTNM
Class A Common Stock
2026-02-24 Sell 4,400 $16.02 70,488
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
2026-02-24 Option exercise 4,400 $0.00
Contineum Therapeutics Inc CTNM
Class A Common Stock
2026-02-24 Sell 4,300 $16.03 68,929
Contineum Therapeutics Inc CTNM
Class A Common Stock
2026-02-24 Option exercise 4,300 $1.01 4,343
Contineum Therapeutics Inc CTNM
Class A Common Stock
2026-02-24 Option exercise 4,400 $1.26 5,544
Contineum Therapeutics Inc CTNM
Class A Common Stock
2026-02-19 Sell 100 $16.00 1,600
Contineum Therapeutics Inc CTNM
Class A Common Stock
2026-02-19 Option exercise 100 $1.01 101
Contineum Therapeutics Inc CTNM
Stock Option (right to buy) · derivative
2026-02-19 Option exercise 100 $0.00
Contineum Therapeutics Inc CTNM
Class A Common Stock
2026-02-11 Sell 400 $16.00 6,400
showing 20 of 98 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com